These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 22929917

  • 1. Association of folate intake, dietary habits, smoking and COX-2 promotor -765G>C polymorphism with K-ras mutation in patients with colorectal cancer.
    Kamal MM, Youssef OZ, Lotfy AN, Elsaed ET, Fawzy MM.
    J Egypt Natl Canc Inst; 2012 Sep; 24(3):115-22. PubMed ID: 22929917
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer.
    Yan ZH, Cui LH, Wang XH, Li C, He X.
    World J Gastroenterol; 2014 Dec 28; 20(48):18338-45. PubMed ID: 25561800
    [Abstract] [Full Text] [Related]

  • 3. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
    Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R.
    Cancer Res; 1997 Mar 15; 57(6):1098-102. PubMed ID: 9067278
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index.
    Xing LL, Wang ZN, Jiang L, Zhang Y, Xu YY, Li J, Luo Y, Zhang X.
    World J Gastroenterol; 2008 Mar 21; 14(11):1785-9. PubMed ID: 18350611
    [Abstract] [Full Text] [Related]

  • 5. Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer.
    Schimanski CC, Moehler M, Gockel I, Zimmermann T, Lang H, Galle PR, Berger MR.
    J Cancer Res Clin Oncol; 2011 Jul 21; 137(7):1139-45. PubMed ID: 21468700
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population.
    Daraei A, Salehi R, Mohamadhashem F.
    Mol Biol Rep; 2012 May 21; 39(5):5219-24. PubMed ID: 22173719
    [Abstract] [Full Text] [Related]

  • 9. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
    Ueda N, Maehara Y, Tajima O, Tabata S, Wakabayashi K, Kono S.
    Cancer Sci; 2008 Mar 21; 99(3):576-81. PubMed ID: 18167131
    [Abstract] [Full Text] [Related]

  • 10. [Cyclooxygenase-2 -765G>C polymorphism and susceptibility to colorectal cancer: a meta-analysis].
    Chen X, Dong W, Wang J, Lyu X, Lei H, Liu Y.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Jan 21; 48(1):62-6. PubMed ID: 24713293
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort.
    Levi M, Prayogi G, Sastranagara F, Sudianto E, Widjajahakim G, Gani W, Mahanadi A, Agnes J, Khairunisa BH, Utomo AR.
    J Gastrointest Cancer; 2018 Jun 21; 49(2):124-131. PubMed ID: 28044264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dietary acrylamide intake and the risk of colorectal cancer with specific mutations in KRAS and APC.
    Hogervorst JG, de Bruijn-Geraets D, Schouten LJ, van Engeland M, de Kok TM, Goldbohm RA, van den Brandt PA, Weijenberg MP.
    Carcinogenesis; 2014 May 21; 35(5):1032-8. PubMed ID: 24398672
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia.
    Zahrani A, Kandil M, Badar T, Abdelsalam M, Al-Faiar A, Ismail A.
    Tumori; 2014 May 21; 100(1):75-9. PubMed ID: 24675495
    [Abstract] [Full Text] [Related]

  • 20. Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab.
    Lurje G, Nagashima F, Zhang W, Yang D, Chang HM, Gordon MA, El-Khoueiry A, Husain H, Wilson PM, Ladner RD, Mauro DJ, Langer C, Rowinsky EK, Lenz HJ.
    Clin Cancer Res; 2008 Dec 01; 14(23):7884-95. PubMed ID: 19047118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.